Study to Compare Capsule and Liquid Formulations of Enzalutamide After Single Dose Administration Under Fasting Conditions in Prostate Cancer
Clinical trial NCT03478904 · TERMINATED
Trial details
- NCT number
- NCT03478904
- Sponsor
- National Cancer Institute (NCI)
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-03-10
- Primary completion
- 2020-11-30
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.